Suppr超能文献

心房颤动发病率及生存率的十年趋势:一项社区研究。

Decade-long trends in atrial fibrillation incidence and survival: a community study.

作者信息

Chamberlain Alanna M, Gersh Bernard J, Alonso Alvaro, Chen Lin Y, Berardi Cecilia, Manemann Sheila M, Killian Jill M, Weston Susan A, Roger Véronique L

机构信息

Department of Health Sciences Research, Mayo Clinic, Rochester, Minn.

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn.

出版信息

Am J Med. 2015 Mar;128(3):260-7.e1. doi: 10.1016/j.amjmed.2014.10.030. Epub 2014 Nov 8.

Abstract

BACKGROUND

Contemporary data on temporal trends in incidence and survival after atrial fibrillation are scarce.

METHODS

Residents of Olmsted County, Minn., with a first-ever atrial fibrillation or atrial flutter event between 2000 and 2010 were identified. Age- and sex-adjusted incidence rates were standardized to the 2010 US population, and the relative risk of atrial fibrillation in 2010 versus 2000 was calculated using Poisson regression. Standardized mortality ratios of observed versus expected survival were calculated, and time trends in survival were examined using Cox regression.

RESULTS

We identified 3344 patients with incident atrial fibrillation/atrial flutter events (52% were male, mean age 72.6 years, 95.7% were white). Incidence did not change over time (age- and sex-adjusted rate ratio, 1.01; 95% confidence interval [CI], 0.91-1.13 for 2010 vs 2000). Within the first 90 days, the risk of all-cause mortality was greatly elevated compared with individuals of a similar age and sex distribution in the general population (standardized mortality ratios 19.4 [95% CI, 17.3-21.7] and 4.2 [95% CI, 3.5-5.0] for the first 30 days and 31 to 90 days after diagnosis, respectively). Survival within the first 90 days did not improve over the study period (adjusted hazard ratio, 0.96; 95% CI, 0.71-1.32 for 2010 vs 2000); likewise, no difference in mortality between 2010 and 2000 was observed among 90-day survivors (hazard ratio, 1.05; 95% CI, 0.85-1.31).

CONCLUSIONS

In the community, atrial fibrillation incidence and survival have remained constant over the last decade. A dramatic and persistent excess risk of death was observed in the 90 days after atrial fibrillation diagnosis, underscoring the importance of early risk stratification.

摘要

背景

关于心房颤动发病率和生存率随时间变化趋势的当代数据匮乏。

方法

确定明尼苏达州奥尔姆斯特德县在2000年至2010年间首次发生心房颤动或心房扑动事件的居民。年龄和性别调整后的发病率根据2010年美国人口进行标准化,并使用泊松回归计算2010年与2000年心房颤动的相对风险。计算观察到的与预期生存的标准化死亡比率,并使用Cox回归检查生存的时间趋势。

结果

我们确定了3344例心房颤动/心房扑动事件患者(52%为男性,平均年龄72.6岁,95.7%为白人)。发病率随时间没有变化(年龄和性别调整后的率比为1.01;2010年与2000年相比,95%置信区间[CI]为0.91 - 1.13)。在最初90天内,与一般人群中年龄和性别分布相似的个体相比,全因死亡风险大幅升高(诊断后第1个30天和第31至90天的标准化死亡比率分别为19.4[95%CI,17.3 - 21.7]和4.2[95%CI,3.5 - 5.0])。在研究期间,最初90天内的生存率没有改善(2010年与2000年相比,调整后的风险比为0.96;95%CI为0.71 - 1.32);同样,在90天幸存者中,2010年和2000年的死亡率没有差异(风险比为1.05;95%CI为0.85 - 1.31)。

结论

在社区中,过去十年心房颤动的发病率和生存率保持不变。在心房颤动诊断后的90天内观察到显著且持续的死亡风险增加,强调了早期风险分层的重要性。

相似文献

6
Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial Fibrillation.心房扑动与心房颤动缺血性卒中的比较风险
J Stroke Cerebrovasc Dis. 2018 Apr;27(4):839-844. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.025. Epub 2017 Dec 6.

引用本文的文献

本文引用的文献

7
Apixaban versus warfarin in patients with atrial fibrillation.阿哌沙班与华法林用于房颤患者。
N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.
8
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动。
N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验